Insiders Cara Therapeutics, Inc.

Equities

CARA

US1407551092

Market Closed - Nasdaq Other stock markets 21:00:00 10/05/2024 BST			5-day change	1st Jan Change
0.7156 ^USD	-5.85%		-8.04%	-3.69%

03-22	Cara Therapeutics, Inc. Announces Resignation of Dr. Joana Goncalves as Chief Medical Officer, Effective April 16, 2024	CI
03-06	Canaccord Genuity Adjusts Cara Therapeutics Price Target to $10 From $11, Maintains Buy Rating	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cara Therapeutics, Inc. Announces Resignation of Dr. Joana Goncalves as Chief Medical Officer, Effective April 16, 2024	03-22	CI
Cara Therapeutics to Cut Workforce Up to 50%, Halt Work on Chronic Kidney Disease; Chief Scientific Officer to Exit	01-22	MT
Cara Therapeutics, Inc. Announces Frédérique Menzaghi Departs as Chief Scientific Officer and SVP of Research & Development, Effective February 2, 2024	01-22	CI
Cara Therapeutics, Inc. Appoints Helen M. Boudreau as Member of Board and Audit Committee	03/08/23	CI
Insider Sell: Cara Therapeutics	18/11/22	MT
Cara Therapeutics Announces Appointment of Lisa Von Moltke, M.D., to Its Board of Directors	03/11/22	CI
Insider Sell: Cara Therapeutics	16/09/22	MT
Cara Therapeutics Appoints Ryan Maynard Chief Financial Officer	12/09/22	MT
Cara Therapeutics, Inc Appoints Ryan Maynard as Principal Financial Officer and Principal Accounting Officer	12/09/22	CI
Cara Therapeutics, Inc Appoints Ryan Maynard to Serve as Chief Financial Officer	12/09/22	CI
Amarin Names Tom Reilly Finance Chief	06/06/22	MT
Cara Therapeutics CFO Thomas Reilly Resigns	06/06/22	MT
Cara Therapeutics, Inc. Announces Resignation of Thomas Reilly as Chief Financial Officer, Effective on or About June 15, 2022	03/06/22	CI
Cara Therapeutics Names Christopher Posner CEO	03/11/21	MT
Cara Therapeutics, Inc. Announces Executive Changes	03/11/21	CI
Cara Therapeutics, Inc. Announces Executive Changes	03/11/21	CI
Insider Sell: Cara Therapeutics	09/09/21	MT
Insider Trends: Insider Prolongs 90-Day Selling Trend at Cara Therapeutics	12/12/20	MT
Insider Trends: Insider Sales Continue 90-Day Trend at Cara Therapeutics	19/11/20	MT
Cara Therapeutics, Inc. Appoints Thomas Reilly as Chief Financial Officer	01/10/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Cara Therapeutics, Inc.

Equities

CARA

US1407551092

Insiders

Filters